Annual Address of the President of Jefferson County, Alabama, Medical Society

por Davis, John D. S.
Publicado 1888

A Case of Subpericranial Cephalæmatoma

por Davis, John. D. S.
Publicado 1885

Electrolysis in Morbid Alterations That Are Produced in the Prostate by Gonorrhoea of the Urethra

por Davis, John D. S.
Publicado 1889

Epicystic Surgical Fistula for Cystoscopic Exploration; Intravesical Treatment and Drainage

por Davis, John D. S.
Publicado 1889

Epicystic Surgical Fistula for Cystoscopic Exploration; Intravesical Treatment and Drainage

por Davis, John D. S.
Publicado 1889

Editorial. Community practice in the time of COVID-19

por Prall, J. Adair, Davis, John D., Jenkins, N. Ross
Publicado 2020

Population pharmacokinetics and exposure–response modeling for evinacumab in homozygous familial hypercholesterolemia

por Pu, Xia, Sale, Mark, Yang, Feng, Zhang, Yi, Davis, John D., Al‐Huniti, Nidal
Publicado 2021

Population pharmacokinetic characteristics of cemiplimab in patients with advanced malignancies

por Yang, Feng, Paccaly, Anne J., Rippley, Ronda K., Davis, John D., DiCioccio, A. Thomas
Publicado 2021

Population pharmacokinetic analysis of dupilumab in adult and adolescent patients with asthma

por Zhang, Li, Gao, Yue, Li, Meng, Xu, Christine, Davis, John D., Kanamaluru, Vanaja, Lu, Qiang
Publicado 2021

Population pharmacokinetics modeling and exposure‐response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer

por Nguyen, Jenny‐Hoa, Epling, Daniel, Dolphin, Nancy, Paccaly, Anne, Conrado, Daniela, Davis, John D., Al‐Huniti, Nidal
Publicado 2022

THU467 Pharmacokinetics And Pharmacodynamics Of Garetosmab In Patients With Fibrodysplasia Ossificans Progressiva

por Wang, Yuhuan, Nguyen, Jenny-Hoa, de Ruiter, Ruben R D, Mendell, Jeanne, Srinivasan, Dushyanth, Davis, John D, Eekhoff, Marelise W
Publicado 2023

A quantitative systems pharmacology modeling platform for evaluating triglyceride profiles in patients with high triglycerides receiving evinacumab

por Khaksar Toroghi, Masood, Bosley, Jim, Powell, Lyn M., Zhang, Yi, Yang, Feng, Pu, Xia, Davis, John D., Al‐Huniti, Nidal
Publicado 2021

Base and Covariate Population Pharmacokinetic Analyses of Dupilumab in Adolescents and Children ≥6 to <12 Years of Age Using Phase 3 Data

por Kovalenko, Pavel, Kamal, Mohamed A., Davis, John D., Huniti, Nidal, Xu, Christine, Bansal, Ashish, Shumel, Brad, DiCioccio, A. Thomas
Publicado 2021

Pharmacokinetics of Subcutaneous Dupilumab Injection With an Autoinjector Device or Prefilled Syringe

por Cohen, Yehuda Z., Zhang, Xiaojia, Xia, Binfeng, Kosloski, Matthew P., Kamal, Mohamed A., Davis, John D., Kanamaluru, Vanaja, Xu, Christine
Publicado 2022

Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab

por Davis, John D., Bansal, Ashish, Hassman, David, Akinlade, Bolanle, Li, Meng, Li, Zhaoyang, Swanson, Brian, Hamilton, Jennifer D., DiCioccio, A. Thomas
Publicado 2018

Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first‐in‐human and first‐in‐patient trials

por Kosloski, Matthew P., Kalliolias, George D., Xu, Christine R., Harel, Sivan, Lai, Ching‐Ha, Zheng, Wenjun, Davis, John D., Kamal, Mohamed A.
Publicado 2021

Population Pharmacodynamic Model of Neutrophil Margination and Tolerance to Describe Effect of Sarilumab on Absolute Neutrophil Count in Patients with Rheumatoid Arthritis

por Kovalenko, Pavel, Paccaly, Anne, Boyapati, Anita, Xu, Christine, St John, Gregory, Nivens, Michael C., Davis, John D., Rippley, Ronda, DiCioccio, A. Thomas
Publicado 2020

Pharmacokinetics and Pharmacodynamics of Subcutaneous Sarilumab and Intravenous Tocilizumab Following Single‐Dose Administration in Patients With Active Rheumatoid Arthritis on Sta...

por Paccaly, Anne J., Kovalenko, Pavel, Parrino, Janie, Boyapati, Anita, Xu, Christine, van Hoogstraten, Hubert, Ishii, Tomonori, Davis, John D., DiCioccio, A. Thomas
Publicado 2020

Combining “Bottom‐up” and “Top‐down” Approaches to Assess the Impact of Food and Gastric pH on Pictilisib (GDC‐0941) Pharmacokinetics

por Lu, Tong, Fraczkiewicz, Grazyna, Salphati, Laurent, Budha, Nageshwar, Dalziel, Gena, Smelick, Gillian S., Morrissey, Kari M., Davis, John D., Jin, Jin Y., Ware, Joseph A.
Publicado 2017

Pharmacokinetics and Pharmacodynamics of Garetosmab (Anti‐Activin A): Results From a First‐in‐Human Phase 1 Study

por Vanhoutte, Frédéric, Liang, Su, Ruddy, Marcella, Zhao, An, Drewery, Tiera, Wang, Yuhuan, DelGizzi, Richard, Forleo‐Neto, Eduardo, Rajadhyaksha, Manoj, Herman, Gary, Davis, John D.
Publicado 2020